Industry Sponsored Symposium

Working Together toward HCV Elimination in People Who Use Substances: A Multidisciplinary Approach 

Join us for an interactive panel session to discuss managing HCV in the context of addiction. We will present a series of best-practice initiatives, interspersed with interactive panel discussions, as we consider the practical implications of community-based care.

Date: Wednesday 11 September

Time: 12.45pm – 1.45pm

Location: Fortifications, Level 9

Lunch will be served outside the room

Timing Title Presenter
12.45–12.50 Welcome and introduction Brian Conway
12.50–13.05 Treating HCV in the PWID Population – Is Simplification the Key? Nancy Reau
13.05–13.20 Addressing Gaps in the Care Cascade for PWID – Focus on Cross-specialty Collaboration Brian Conway
13.20–13.35 Prison-Experienced PWID – Maintaining a Connection to Care Lisa BarrettAll
13.35–13.45 Q&A and Summary All

A step closer to achieving HCV elimination in substance users

Date: Thursday 12 September 2019 

Time: 8.00am - 8.45am

 Location: Fortifications, level 9

Moderator: Prof Ashley Brown, BSc MBChB MD FRCP- St Mary’s Hospital London, UK

• Prof Ashley Brown, BSc MBChB MD FRCP- St Mary’s Hospital London, UK
“The role of new diagnostics in global elimination of HCV”

• Prof. Jeffrey V. Lazarus, PhD, MIH, MA- Barcelona Institute of Global Health, Spain
"Models of Care to reach PWID with HCV services"

• Ms Hazel Heal, 'Hep C Awareness and Treatment Advocate' to Families for Sensible Drug Policy- Hep C Action, New Zealand

'"We have lift off” Patient power: New symbol turns tide on global Hepatitis C stigma to increase testing.’
Discussion panel

Transforming HCV care: the power of collaboration

Date: Thursday 12 September 2019 

Time: 12.45–1.45 pm

 Location: Montréal, Canada

Timing Title Presenter
12.45–12.55 Welcome and introduction Chris Fraser (Canada)
12.55–13.20 Harm reduction – is it a one-way street? Anthony Martinez (USA) &
Valgerdur Runarsdóttir (Iceland)
13.20–13.40 Task-shifting – what is possible in the pangenotypic era? Valgerdur Runarsdóttir (Iceland)
Anthony Martinez (USA)
13.40–13.45 Summary and close Chris Fraser (Canada)